Another way to look at it….the third party manufacturer appears to be in Europe….i thought initially it was in India…but kiwi changed my mine when European fda equivalents had no issue with the manufacturer…..kgarner told me Uncy wants to launch product here first then attack the EU….if the fda screws is again with another crl I say ok we’ll just concentrate on the EU market since a buyout would probably come from a EU pharmaceutical anyway….just go to plan b
Market Data 
Markets 
AI
